Seres Therapeutics, Inc. (MCRB)
2.94
+0.01
(+0.34%)
USD |
NASDAQ |
Oct 02, 16:00
2.93
-0.01
(-0.34%)
After-Hours: 20:00
Seres Therapeutics Market Cap : 28.89M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 28.89M |
| October 01, 2026 | 28.79M |
| September 30, 2026 | 32.92M |
| September 29, 2026 | 34.20M |
| September 28, 2026 | 34.59M |
| September 25, 2026 | 34.59M |
| September 24, 2026 | 35.58M |
| September 23, 2026 | 37.25M |
| September 22, 2026 | 39.51M |
| September 21, 2026 | 40.00M |
| September 18, 2026 | 39.31M |
| September 17, 2026 | 40.29M |
| September 16, 2026 | 41.37M |
| September 15, 2026 | 45.21M |
| September 14, 2026 | 46.48M |
| September 11, 2026 | 49.24M |
| September 10, 2026 | 50.12M |
| September 09, 2026 | 51.89M |
| September 08, 2026 | 54.64M |
| September 04, 2026 | 56.21M |
| September 03, 2026 | 55.43M |
| September 02, 2026 | 54.44M |
| September 01, 2026 | 50.91M |
| August 31, 2026 | 48.25M |
| August 28, 2026 | 50.22M |
| Date | Value |
|---|---|
| August 27, 2026 | 48.65M |
| August 26, 2026 | 46.78M |
| August 25, 2026 | 49.14M |
| August 24, 2026 | 45.80M |
| August 21, 2026 | 44.81M |
| August 20, 2026 | 44.91M |
| August 19, 2026 | 45.99M |
| August 18, 2026 | 42.65M |
| August 17, 2026 | 44.32M |
| August 14, 2026 | 44.62M |
| August 13, 2026 | 44.03M |
| August 12, 2026 | 46.39M |
| August 11, 2026 | 45.60M |
| August 10, 2026 | 49.14M |
| August 07, 2026 | 47.86M |
| August 06, 2026 | 47.37M |
| August 05, 2026 | 49.19M |
| August 04, 2026 | 51.59M |
| August 03, 2026 | 49.43M |
| July 31, 2026 | 46.33M |
| July 30, 2026 | 45.85M |
| July 29, 2026 | 44.60M |
| July 28, 2026 | 46.04M |
| July 27, 2026 | 46.52M |
| July 24, 2026 | 47.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 356.27M |
| Amgen, Inc. | 217.88B |
| BioCryst Pharmaceuticals, Inc. | 2.086B |
| Imunon, Inc. | 5.972M |
| Curis, Inc. | 1.566M |
Market Cap Related Metrics
| PS Ratio | 14.70 |
| PEG Ratio | -0.0058 |
| Price to Book Value | 0.8367 |
| Price | 2.94 |
| Earnings Yield | -77.46% |
| PEGY Ratio | -0.0058 |